
-
US tariffs to kick in Aug 1, barring trade deals
-
Trump slams former ally Musk's political party as 'ridiculous'
-
Three things we learned from the second England-India Test
-
Norway reach Euro 2025 quarter-finals as Swiss down eliminated Iceland
-
Alcaraz vows to avoid Murray after defeat on golf course
-
Alcaraz finds magic touch at Wimbledon as Sabalenka storms into quarter-finals
-
Run-hungry Gill glad to 'lead by example' as India level England series
-
Rockets confirm arrival of Durant in unprecedented NBA seven-team trade
-
Alcaraz survives Rublev test to stay on course for Wimbledon hat-trick
-
New Zealand's Dixon wins seventh IndyCar Mid-Ohio title
-
US tariffs to kick in Aug 1, barring trade deals: Bessent
-
England consider Archer and Atkinson recall after heavy India defeat
-
Durant deal becomes NBA-record seven-team trade: reports
-
Verstappen laments 'really difficult' Silverstone fifth
-
BRICS nations hit out at Trump tariffs
-
Hansen shoots Norway to brink of Euro 2025 quarter-finals
-
Jennifer Geerlings-Simons becomes Suriname's first woman president
-
Netanyahu says Trump meeting could 'advance' Gaza deal ahead of Doha talks
-
BRICS meeting in Rio hits out at Trump tariffs
-
Hulkenberg shakes off F1's longest unwanted record with podium finish at Silverstone
-
US tariffs to kick in Aug 1 barring trade deals: Treasury Secretary
-
Norris in dream land after epic home win at Silverstone
-
Sabalenka storms into Wimbledon quarters as Alcaraz braces for Rublev test
-
Sabalenka downs former doubles partner to power into Wimbledon quarters
-
'Jurassic World: Rebirth' roars to top of N.American box office
-
Wimbledon's underdogs enjoy their week in the sun
-
Deep strikes as India hammer England in second Test
-
Sabalenka powers into Wimbledon quarter-finals
-
Dutch powerhouse Van der Poel takes Tour de France lead
-
Emotional Norris wins epic rain-hit British Grand Prix
-
Australian pacemen rattle West Indies run chase
-
Syria fights 'catastrophic' fires for fourth day
-
'Stole the game': Wimbledon line-calling tech malfunctions
-
Van der Poel powers into Tour de France lead
-
Norris wins home British Grand Prix
-
Wimbledon line-calling tech malfunctions
-
BRICS gather in Rio as Trump tariff wars loom
-
Bayern's Musiala out for 'long period' with broken fibula
-
Deep leaves England on brink of defeat as India eye series-levelling win
-
Caldentey's Arsenal stint boosting her bid for Euros and Ballon d'Or glory
-
Fritz into Wimbledon quarter-finals after Thompson retires
-
Armed gang attacks Kenya Human Rights Commission on eve of protests
-
Hezbollah chief says won't surrender under Israeli threats
-
Arsenal sign Spain midfielder Zubimendi
-
India resume quest to level England series after rain delay
-
Arsenal sign midfielder Zubimendi from Real Sociedad
-
Alcaraz seeks top gear at Wimbledon as Sabalenka stays calm
-
'Emergency' at Afghan border as migrant returns from Iran surge ahead of deadline
-
Rain delays India's bid for win over England in second Test
-
Gaza truce talks to resume in Doha before Netanyahu heads to US

Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
P.Santos--AMWN